Q&A With Scott Whitaker: AdvaMed's Next CEO On The Path Ahead
This article was originally published in The Gray Sheet
AdvaMed's board just selected Scott Whitaker, a top executive at the Biotechnology Innovation Organization, as the trade group's next CEO. Before he starts in the new role on April 4, he spoke with The Gray Sheet about his vision.
Register for our free email digests: